$GWPH Recent Headlines
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome 8:01 a.m. Feb. 28, 2014 - benzinga.com
Why Cara Therapeutics May Be A Better Opportunity Than GW Pharmaceuticals 4:02 p.m. Feb. 27, 2014 - Seeking Alpha
GW Pharmaceuticals: High As A Kite And Too Close To The Sun 11:04 a.m. Feb. 20, 2014 - Seeking Alpha
Canaccord Fumes Over Pot Deal 12:39 p.m. Feb. 14, 2014 - TheStreet.com
Piper Sees "Meaningful Utility" from GW Phamaceuticals CBD, Reiterates Overweight Rating 4:19 p.m. Feb. 7, 2014 - benzinga.com
GW Pharmaceuticals' CEO Discusses F1Q14 Results - Earnings Call Transcript 8:15 p.m. Feb. 5, 2014 - Seeking Alpha
GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6% - Tale of the Tape 10:18 a.m. Feb. 5, 2014 - Zacks.com
Can GW Pharma (GWPH) Continue to Rise? - Tale of the Tape 7:36 a.m. Feb. 4, 2014 - Zacks.com
GW Pharmaceuticals - A Marijuana Stock With Monster Potential If Sativex Wins U.S Approval 3:52 p.m. Jan. 13, 2014 - Seeking Alpha
Capitalizing On Cannabis: Key Considerations For Cannabis Stock Investors 9:05 a.m. Jan. 13, 2014 - Seeking Alpha
Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble 6:25 p.m. Jan. 9, 2014 - Seeking Alpha
GW Pharmaceuticals Prices 2.44M ADS Offering at $36.00/ADS 6:06 a.m. Jan. 9, 2014 - benzinga.com
High times are here for Colorado marijuana sellers, risk-tolerant investors 5:49 p.m. Jan. 3, 2014 - Seeking Alpha
High times are here for Colorado marijuana sellers, risk-tolerant investors 5:49 p.m. Jan. 3, 2014 - Seeking Alpha
The 5 Hottest IPOs of 2013 4:45 a.m. Dec. 4, 2013 - InvestorPlace.com
GW Pharma's Sativex Gets Swiss Nod - Analyst Blog 7:10 p.m. Nov. 29, 2013 - Zacks.com
UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns 10:47 a.m. Nov. 27, 2013 - benzinga.com
Capitalizing On Cannabis: New Leaders Emerge From A Cloud Of Pink Smoke 7:05 a.m. Nov. 25, 2013 - Seeking Alpha
GW Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call 2:34 p.m. Nov. 19, 2013 - Seeking Alpha
Medical Marijuana, Inc: Definitely A Dope Opera 8:00 a.m. Nov. 18, 2013 - Seeking Alpha
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome 9:00 a.m. Feb. 28, 2014 - GlobeNewswire
GW Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference 6:00 p.m. Feb. 26, 2014 - GlobeNewswire
Cannabis Sector's High Volume Trading Report - Company Enters Into Agreement with a Colorado Marijuana Facility Developer 9:50 a.m. Feb. 26, 2014 - PR Newswire - PRF
Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products 11:16 a.m. Feb. 20, 2014 - PR Newswire - PRF
Medical Marijuana Explosion Continues as Company Agrees to Purchase 83,000 S/F Complex in AZ 9:50 a.m. Feb. 19, 2014 - PR Newswire - PRF
GW Pharmaceuticals to Present at the Leerink Global Healthcare Conference 1:00 p.m. Feb. 10, 2014 - GlobeNewswire
Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New Dispensary Sites 10:02 a.m. Feb. 5, 2014 - PR Newswire - PRF
GW Pharmaceuticals plc Reports First Quarter 2014 Financial Results and Operational Progress 3:00 a.m. Feb. 5, 2014 - GlobeNewswire
GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014 3:00 a.m. Jan. 29, 2014 - GlobeNewswire
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014 12:26 p.m. Jan. 22, 2014 - BusinessWire - BZX
GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs 12:18 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 9:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America 3:00 a.m. Jan. 14, 2014 - GlobeNewswire
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America 2:00 a.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 12:19 p.m. Jan. 13, 2014 - ACCESSWIRE
GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market 12:05 a.m. Jan. 9, 2014 - PR Newswire
GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering 10:07 a.m. Dec. 20, 2013 - PR Newswire
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma 3:00 a.m. Dec. 11, 2013 - PR Newswire
Edison highlights the potential of GW Pharmaceuticals' cannabinoid pipeline and furthers its US healthcare presence 11:01 a.m. Dec. 10, 2013 - PR Newswire
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare 9:00 a.m. Dec. 2, 2013 - PR Newswire
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome 8:01 a.m. Feb. 28, 2014 - benzinga.com
Why Cara Therapeutics May Be A Better Opportunity Than GW Pharmaceuticals 4:02 p.m. Feb. 27, 2014 - Seeking Alpha
GW Pharmaceuticals: High As A Kite And Too Close To The Sun 11:04 a.m. Feb. 20, 2014 - Seeking Alpha
Canaccord Fumes Over Pot Deal 12:39 p.m. Feb. 14, 2014 - TheStreet.com
Piper Sees "Meaningful Utility" from GW Phamaceuticals CBD, Reiterates Overweight Rating 4:19 p.m. Feb. 7, 2014 - benzinga.com
GW Pharmaceuticals' CEO Discusses F1Q14 Results - Earnings Call Transcript 8:15 p.m. Feb. 5, 2014 - Seeking Alpha
GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6% - Tale of the Tape 10:18 a.m. Feb. 5, 2014 - Zacks.com
Can GW Pharma (GWPH) Continue to Rise? - Tale of the Tape 7:36 a.m. Feb. 4, 2014 - Zacks.com
GW Pharmaceuticals - A Marijuana Stock With Monster Potential If Sativex Wins U.S Approval 3:52 p.m. Jan. 13, 2014 - Seeking Alpha
Capitalizing On Cannabis: Key Considerations For Cannabis Stock Investors 9:05 a.m. Jan. 13, 2014 - Seeking Alpha
Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble 6:25 p.m. Jan. 9, 2014 - Seeking Alpha
GW Pharmaceuticals Prices 2.44M ADS Offering at $36.00/ADS 6:06 a.m. Jan. 9, 2014 - benzinga.com
High times are here for Colorado marijuana sellers, risk-tolerant investors 5:49 p.m. Jan. 3, 2014 - Seeking Alpha
High times are here for Colorado marijuana sellers, risk-tolerant investors 5:49 p.m. Jan. 3, 2014 - Seeking Alpha
The 5 Hottest IPOs of 2013 4:45 a.m. Dec. 4, 2013 - InvestorPlace.com
GW Pharma's Sativex Gets Swiss Nod - Analyst Blog 7:10 p.m. Nov. 29, 2013 - Zacks.com
UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns 10:47 a.m. Nov. 27, 2013 - benzinga.com
Capitalizing On Cannabis: New Leaders Emerge From A Cloud Of Pink Smoke 7:05 a.m. Nov. 25, 2013 - Seeking Alpha
GW Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call 2:34 p.m. Nov. 19, 2013 - Seeking Alpha
Medical Marijuana, Inc: Definitely A Dope Opera 8:00 a.m. Nov. 18, 2013 - Seeking Alpha
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome 9:00 a.m. Feb. 28, 2014 - GlobeNewswire
GW Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference 6:00 p.m. Feb. 26, 2014 - GlobeNewswire
Cannabis Sector's High Volume Trading Report - Company Enters Into Agreement with a Colorado Marijuana Facility Developer 9:50 a.m. Feb. 26, 2014 - PR Newswire - PRF
Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products 11:16 a.m. Feb. 20, 2014 - PR Newswire - PRF
Medical Marijuana Explosion Continues as Company Agrees to Purchase 83,000 S/F Complex in AZ 9:50 a.m. Feb. 19, 2014 - PR Newswire - PRF
GW Pharmaceuticals to Present at the Leerink Global Healthcare Conference 1:00 p.m. Feb. 10, 2014 - GlobeNewswire
Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New Dispensary Sites 10:02 a.m. Feb. 5, 2014 - PR Newswire - PRF
GW Pharmaceuticals plc Reports First Quarter 2014 Financial Results and Operational Progress 3:00 a.m. Feb. 5, 2014 - GlobeNewswire
GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014 3:00 a.m. Jan. 29, 2014 - GlobeNewswire
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014 12:26 p.m. Jan. 22, 2014 - BusinessWire - BZX
GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs 12:18 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 9:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America 3:00 a.m. Jan. 14, 2014 - GlobeNewswire
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America 2:00 a.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 12:19 p.m. Jan. 13, 2014 - ACCESSWIRE
GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market 12:05 a.m. Jan. 9, 2014 - PR Newswire
GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering 10:07 a.m. Dec. 20, 2013 - PR Newswire
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma 3:00 a.m. Dec. 11, 2013 - PR Newswire
Edison highlights the potential of GW Pharmaceuticals' cannabinoid pipeline and furthers its US healthcare presence 11:01 a.m. Dec. 10, 2013 - PR Newswire
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare 9:00 a.m. Dec. 2, 2013 - PR Newswire
